Cargando…

Systems pharmacology augments drug safety surveillance

Small molecule drugs are the foundation of modern medical practice yet their use is limited by the onset of unexpected and severe adverse events (AEs). Regulatory agencies rely on post-marketing surveillance to monitor safety once drugs are approved for clinical use. Despite advances in pharmacovigi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lorberbaum, Tal, Nasir, Mavra, Keiser, Michael J., Vilar, Santiago, Hripcsak, George, Tatonetti, Nicholas P.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	2014
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4325423/ https://www.ncbi.nlm.nih.gov/pubmed/25670520 http://dx.doi.org/10.1002/cpt.2

Ejemplares similares

Improving Detection of Arrhythmia Drug-Drug Interactions in Pharmacovigilance Data through the Implementation of Similarity-Based Modeling
por: Vilar, Santiago, et al.
Publicado: (2015)

3D Pharmacophoric Similarity improves Multi Adverse Drug Event Identification in Pharmacovigilance
por: Vilar, Santiago, et al.
Publicado: (2015)

An Integrative Data Science Pipeline to Identify Novel Drug Interactions that Prolong the QT Interval
por: Lorberbaum, Tal, et al.
Publicado: (2016)

Leveraging 3D chemical similarity, target and phenotypic data in the identification of drug-protein and drug-adverse effect associations
por: Vilar, Santiago, et al.
Publicado: (2016)

Comparative analysis, applications, and interpretation of electronic health record-based stroke phenotyping methods
por: Thangaraj, Phyllis M., et al.
Publicado: (2020)

Detection of Drug-Drug Interactions by Modeling Interaction Profile Fingerprints
por: Vilar, Santiago, et al.
Publicado: (2013)

Development and validation of a classification approach for extracting severity automatically from electronic health records
por: Boland, Mary Regina, et al.
Publicado: (2015)

No population left behind: Improving paediatric drug safety using informatics and systems biology
por: Giangreco, Nicholas P., et al.
Publicado: (2021)

Birth month affects lifetime disease risk: a phenome-wide method
por: Boland, Mary Regina, et al.
Publicado: (2015)

Columbia Open Health Data, clinical concept prevalence and co-occurrence from electronic health records
por: Ta, Casey N., et al.
Publicado: (2018)

Computational Drug Target Screening through Protein Interaction Profiles
por: Vilar, Santiago, et al.
Publicado: (2016)

Predicting drug side-effects by chemical systems biology
por: Tatonetti, Nicholas P, et al.
Publicado: (2009)

Tissue‐Specific Analysis of Pharmacological Pathways
por: Hao, Yun, et al.
Publicado: (2018)

Similarity-Based Modeling Applied to Signal Detection in Pharmacovigilance
por: Vilar, S, et al.
Publicado: (2014)

A curated and standardized adverse drug event resource to accelerate drug safety research
por: Banda, Juan M., et al.
Publicado: (2016)

Feasibility of Prioritizing Drug–Drug-Event Associations Found in Electronic Health Records
por: Banda, Juan M., et al.
Publicado: (2015)

A Drug Safety Rating System Based on Postmarketing Costs Associated with Adverse Events and Patient Outcomes
por: Hoffman, Keith B., et al.
Publicado: (2015)

Pharmacological Augmentation of Endothelium-Derived Nitric Oxide Synthesis
por: Bakris, George L.
Publicado: (2007)

Using Machine Learning to Identify Adverse Drug Effects Posing Increased Risk to Women
por: Chandak, Payal, et al.
Publicado: (2020)

Evaluating risk detection methods to uncover ontogenic-mediated adverse drug effect mechanisms in children
por: Giangreco, Nicholas P., et al.
Publicado: (2021)

The Chemical Basis of Pharmacology
por: Keiser, Michael J., et al.
Publicado: (2010)

Informatics and Computational Methods in Natural Product Drug Discovery: A Review and Perspectives
por: Romano, Joseph D., et al.
Publicado: (2019)

Mapping the effects of drugs on the immune system
por: Kidd, Brian A, et al.
Publicado: (2015)

Next Generation Syndromic Surveillance: Molecular Epidemiology, Electronic Health Records and the Pandemic Influenza A (H1N1) Virus
por: Rabadan, Raul, et al.
Publicado: (2009)

Pharmacological Augmentation of Psychosocial and Remediation Training Efforts in Schizophrenia
por: Harvey, Philip D., et al.
Publicado: (2017)

The Weber Effect and the United States Food and Drug Administration’s Adverse Event Reporting System (FAERS): Analysis of Sixty-Two Drugs Approved from 2006 to 2010
por: Hoffman, Keith B., et al.
Publicado: (2014)

Drug surveillance: the role of the Committee on Safety of Medicines.
por: Griffin, J. P.
Publicado: (1972)

Vaccine Safety Surveillance Using Routinely Collected Healthcare Data—An Empirical Evaluation of Epidemiological Designs
por: Schuemie, Martijn J., et al.
Publicado: (2022)

Development of A Machine Learning Algorithm to Classify Drugs Of Unknown Fetal Effect
por: Boland, Mary Regina, et al.
Publicado: (2017)

Erratum to: The Weber Effect and the United States Food and Drug Administration’s Adverse Event Reporting System (FAERS): Analysis of Sixty-Two Drugs Approved from 2006 to 2010
por: Hoffman, Keith B., et al.
Publicado: (2014)

An Evaluation of “Drug Ineffective” Postmarketing Reports in Drug Safety Surveillance
por: Misu, Takashi, et al.
Publicado: (2018)

Complex Factors and Challenges that Affect the Pharmacology, Safety and Efficacy of Nanocarrier Drug Delivery Systems
por: Piscatelli, Joseph A., et al.
Publicado: (2021)

Stimulated Reporting: The Impact of US Food and Drug Administration-Issued Alerts on the Adverse Event Reporting System (FAERS)
por: Hoffman, Keith B., et al.
Publicado: (2014)

Corrigendum: Vaccine safety surveillance using routinely collected healthcare data—An empirical evaluation of epidemiological designs
por: Schuemie, Martijn J., et al.
Publicado: (2022)

Serially Combining Epidemiological Designs Does Not Improve Overall Signal Detection in Vaccine Safety Surveillance
por: Arshad, Faaizah, et al.
Publicado: (2023)

Cassia auriculata: Aspects of Safety Pharmacology and Drug Interaction
por: Puranik, Amrutesh S., et al.
Publicado: (2011)

Information systems for vaccine safety surveillance
por: Buttery, Jim P, et al.
Publicado: (2022)

Pharmacological Augmentation in Unipolar Depression: A Guide to the Guidelines
por: Taylor, Rachael W, et al.
Publicado: (2020)

Pharmacology and Safety
Publicado: (2021)

The Food and Drug Administration’s (FDA’s) Drug Safety Surveillance During the COVID-19 Pandemic
por: Diak, Ida-Lina, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_8qbfbp3nalnqr22kdgtae6rceb